Evidence map›Paper›PMID 18712538›Full record

ArticleJournal of industrial microbiology & biotechnology2008

Photodynamic inactivation of recombinant bioluminescent Escherichia coli by cationic porphyrins under artificial and solar irradiation.

Eliana Alves, Carla M B Carvalho, João P C Tomé, Maria A F Faustino, Maria G P M S Neves, Augusto C Tomé, José A S Cavaleiro, Angela Cunha, Sónia Mendo, Adelaide Almeida

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Application of the Resazurin Cell Viability Assay to MonitorAntibiotics (Basel, Switzerland) · 2021
    Article
  3. Bacteriophages with Potential to InactivateAntibiotics (Basel, Switzerland) · 2021
    Article
  4. Photodynamic inactivation ofBiology letters · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. 5,10,15,20-Tetra-kis(1-methyl-pyridinium-4-yl)porphyrin tetra-iodide tetra-hydrate.Acta crystallographica. Section E, Structure reports online · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eliana AlvesDepartment of Biology, CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.
Carla M B Carvalho
João P C Tomé
Maria A F Faustino
Maria G P M S Neves
Augusto C Tomé
José A S Cavaleiro
Angela Cunha
Sónia Mendo
Adelaide Almeida

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A faster and simpler method to monitor the photoinactivation process of Escherichia coli involving the use of recombinant bioluminescent bacteria is described here. Escherichia coli cells were transformed with luxCDABE genes from the marine bioluminescent bacterium Vibrio fischeri and the recombinant bioluminescent indicator strain was used to assess, in real time, the effect of three cationic meso-substituted porphyrin derivatives on their metabolic activity, under artificial (40 W m(-2)) and solar irradiation (approximately 620 W m(-2)). The photoinactivation of bioluminescent E. coli is effective (>4 log bioluminescence decrease) with the three porphyrins used, the tricationic porphyrin Tri-Py+-Me-PF being the most efficient compound. The photoinactivation process is efficient both with solar and artificial light, for the three porphyrins tested. The results show that bioluminescence analysis is an efficient and sensitive approach being, in addition, more affordable, faster, cheaper and much less laborious than conventional methods. This approach can be used as a screening method for bacterial photoinactivation studies in vitro and also for the monitoring of the efficiency of novel photosensitizer molecules. As far as we know, this is the first study involving the use of bioluminescent bacteria to monitor the antibacterial activity of porphyrins under environmental conditions.

Indexed as

Aliivibrio fischeriAnti-Bacterial AgentsBacterial ProteinsEscherichia coliLuminescent ProteinsMicrobial ViabilityPhotosensitizing AgentsPorphyrinsRecombinant ProteinsAnti-Bacterial AgentsBacterial ProteinsLuminescent ProteinsPhotosensitizing AgentsPorphyrinsRecombinant Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.